Bibliographic Citation
| - DohanAnthony, GallixBenoit, GuiuBoris, Le MalicotKarine, ReinholdCaroline, SoyerPhilippe, BennounaJaafar, GhiringhelliFrançois, BarbierEmilie, BoigeValérie, TaiebJulien, BouchéOlivier, FrançoisEric, PhélipJean-Marc, BorelChristian, FarouxRoger, SeitzJean-François, JacquotStéphane, Ben AbdelghaniMeher, Khemissa-AkouzFaiza, GenetDominique, JouveJean Louis, Rinaldiyves, DesseigneFrançoise, TexereauPatrick, SucEtienne, LepageCome, AparicioThomas, HoeffelChristine. Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab. Gut, BMJ Publishing Group, 2020, 69 (3), pp.531-539. ⟨10.1136/gutjnl-2018-316407⟩
- DohanAnthony, GallixBenoit, GuiuBoris, Le MalicotKarine, ReinholdCaroline, SoyerPhilippe, BennounaJaafar, GhiringhelliFrançois, BarbierEmilie, BoigeValérie, TaiebJulien, BouchéOlivier, FrançoisEric, PhélipJean-Marc, BorelChristian, FarouxRoger, SeitzJean-François, JacquotStéphane, Ben AbdelghaniMeher, Khemissa-AkouzFaiza, GenetDominique, JouveJean Louis, RinaldiYves, DesseigneFrançoise, TexereauPatrick, SucEtienne, LepageCome, AparicioThomas, HoeffelChristine . Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab . Gut, 2020, 69 (3), pp.531-539 . ⟨10.1136/gutjnl-2018-316407⟩
|